Advertisement

Ads Placeholder
Loading...

Enlitic, Inc.

ENL.AXASX
Healthcare
Medical - Healthcare Information Services
$0.009
$0.00(0.00%)
Australian Market is Open • 11:13

Enlitic, Inc. Fundamental Analysis

Enlitic, Inc. (ENL.AX) shows weak financial fundamentals with a PE ratio of -0.08, profit margin of -14.12%, and ROE of -1.39%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position416.87%
PEG Ratio-0.00
Current Ratio2.99

Areas of Concern

ROE-1.39%
Operating Margin-14.73%
We analyze ENL.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1460.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1460.5/100

We analyze ENL.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ENL.AX struggles to generate sufficient returns from assets.

ROA > 10%
-1.07%

Valuation Score

Excellent

ENL.AX trades at attractive valuation levels.

PE < 25
-0.08
PEG Ratio < 2
-0.00

Growth Score

Weak

ENL.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ENL.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
2.99

Profitability Score

Weak

ENL.AX struggles to sustain strong margins.

ROE > 15%
-138.72%
Net Margin ≥ 15%
-14.12%
Positive Free Cash Flow
No

Key Financial Metrics

Is ENL.AX Expensive or Cheap?

P/E Ratio

ENL.AX trades at -0.08 times earnings. This suggests potential undervaluation.

-0.08

PEG Ratio

When adjusting for growth, ENL.AX's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Enlitic, Inc. at 0.11 times its book value. This may indicate undervaluation.

0.11

EV/EBITDA

Enterprise value stands at -0.80 times EBITDA. This is generally considered low.

-0.80

How Well Does ENL.AX Make Money?

Net Profit Margin

For every $100 in sales, Enlitic, Inc. keeps $-14.12 as profit after all expenses.

-14.12%

Operating Margin

Core operations generate -14.73 in profit for every $100 in revenue, before interest and taxes.

-14.73%

ROE

Management delivers $-1.39 in profit for every $100 of shareholder equity.

-1.39%

ROA

Enlitic, Inc. generates $-1.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Enlitic, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Enlitic, Inc. generates weak or negative free cash flow of $-66.34M, restricting financial flexibility.

$-66.34M

FCF Per Share

Each share generates $-0.08 in free cash annually.

$-0.08

FCF Yield

ENL.AX converts -2.93% of its market value into free cash.

-2.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.80

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.99

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.39

vs 25 benchmark

ROA

Return on assets percentage

-1.07

vs 25 benchmark

ROCE

Return on capital employed

-1.41

vs 25 benchmark

How ENL.AX Stacks Against Its Sector Peers

MetricENL.AX ValueSector AveragePerformance
P/E Ratio-0.0828.54 Better (Cheaper)
ROE-138.72%738.00% Weak
Net Margin-1412.41%-43982.00% (disorted) Weak
Debt/Equity0.030.34 Strong (Low Leverage)
Current Ratio2.992806.01 Strong Liquidity
ROA-107.32%-14624.00% (disorted) Weak

ENL.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Enlitic, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ